{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:54:57Z","timestamp":1762001697280},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T00:00:00Z","timestamp":1332892800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0034217","type":"journal-article","created":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T21:11:54Z","timestamp":1332969114000},"page":"e34217","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["Pharmacogenetic Association of NOS3 Variants with Cardiovascular Disease in Patients with Hypertension: The GenHAT Study"],"prefix":"10.1371","volume":"7","author":[{"given":"Xue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy I.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles E.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Boerwinkle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Eckfeldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Leiendecker-Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna K.","family":"Arnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,3,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJM200108163450709","article-title":"Control of hypertension\u2013an important national priority.","volume":"345","author":"AV Chobanian","year":"2001","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.290.2.199","article-title":"Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988\u20132000.","volume":"290","author":"I Hajjar","year":"2003","journal-title":"Jama"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.vph.2005.09.010","article-title":"Pharmacogenetics of antihypertensive treatment.","volume":"44","author":"DK Arnett","year":"2006","journal-title":"Vascul Pharmacol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2217\/14622416.8.12.1723","article-title":"Endothelial nitric oxide synthase gene: prospects for treatment of heart disease.","volume":"8","author":"GE Cooke","year":"2007","journal-title":"Pharmacogenomics"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1161\/01.CIR.97.25.2494","article-title":"Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis.","volume":"97","author":"BS Oemar","year":"1998","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1373\/49.3.389","article-title":"Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease.","volume":"49","author":"MG Colombo","year":"2003","journal-title":"Clin Chem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/heart.87.6.525","article-title":"Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298\u2013>Asp polymorphism) to the presence, extent, and severity of coronary artery disease.","volume":"87","author":"MG Colombo","year":"2002","journal-title":"Heart"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.mca.0000073080.69657.71","article-title":"The Glu298Asp polymorphism in the endothelial nitric oxide synthase gene is strongly associated with coronary spasm.","volume":"14","author":"K Chang","year":"2003","journal-title":"Coron Artery Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00380-005-0902-0","article-title":"The relationship between endothelial nitric oxide synthase gene polymorphism (T-786 C) and coronary artery disease in the Turkish population.","volume":"21","author":"B Tangurek","year":"2006","journal-title":"Heart Vessels"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1161\/01.HYP.32.3.521","article-title":"Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction.","volume":"32","author":"K Hibi","year":"1998","journal-title":"Hypertension"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1161\/01.CIR.100.14.1515","article-title":"A common variant of the endothelial nitric oxide synthase (Glu298\u2013>Asp) is a major risk factor for coronary artery disease in the UK.","volume":"100","author":"AD Hingorani","year":"1999","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1161\/01.HYP.32.1.3","article-title":"Endothelial nitric oxide synthase gene is positively associated with essential hypertension.","volume":"32","author":"Y Miyamoto","year":"1998","journal-title":"Hypertension"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/sj.jhh.1002096","article-title":"Association analysis of endothelial nitric oxide synthase gene polymorphism with primary hypertension in a Singapore population.","volume":"20","author":"KT Moe","year":"2006","journal-title":"J Hum Hypertens"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1161\/01.STR.29.9.1908","article-title":"Endothelial nitric oxide synthase exon 7 polymorphism, ischemic cerebrovascular disease, and carotid atheroma.","volume":"29","author":"HS Markus","year":"1998","journal-title":"Stroke"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0008-6363(03)00505-4","article-title":"Amlodipine activates the endothelial nitric oxide synthase by altering phosphorylation on Ser1177 and Thr495.","volume":"59","author":"H Lenasi","year":"2003","journal-title":"Cardiovasc Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jama.299.3.296","article-title":"Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension.","volume":"299","author":"AI Lynch","year":"2008","journal-title":"Jama"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0895-7061(96)00037-4","article-title":"Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group.","volume":"9","author":"BR Davis","year":"1996","journal-title":"Am J Hypertens"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00004872-200202000-00024","article-title":"Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study.","volume":"20","author":"G de Simone","year":"2002","journal-title":"J Hypertens"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.gene.6364225","article-title":"Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease.","volume":"6","author":"JC Burns","year":"2005","journal-title":"Genes Immun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.atherosclerosis.2007.02.008","article-title":"Association of polymorphisms in NOS3 with the ankle-brachial index in hypertensive adults.","volume":"196","author":"IJ Kullo","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1161\/01.STR.0000177978.97428.53","article-title":"Promoter polymorphisms in the nitric oxide synthase 3 gene are associated with ischemic stroke susceptibility in young black women.","volume":"36","author":"TD Howard","year":"2005","journal-title":"Stroke"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1042\/CS20080476","article-title":"A common variant of the eNOS gene (E298D) is an independent risk factor for left ventricular hypertrophy in human essential hypertension.","volume":"117","author":"Y Xin","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/sj.tpj.6500113","article-title":"Pharmacogenetic approaches to hypertension therapy: design and rationale for the Genetics of Hypertension Associated Treatment (GenHAT) study.","volume":"2","author":"DK Arnett","year":"2002","journal-title":"Pharmacogenomics J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/mgme.2000.3033","article-title":"Endothelial nitric oxide synthase gene sequence variations and vascular disease.","volume":"70","author":"XL Wang","year":"2000","journal-title":"Mol Genet Metab"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/hmg\/11.3.229","article-title":"Modifier effect of ENOS in autosomal dominant polycystic kidney disease.","volume":"11","author":"A Persu","year":"2002","journal-title":"Hum Mol Genet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1073\/pnas.97.6.2832","article-title":"Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298.","volume":"97","author":"M Tesauro","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/hy1201.097305","article-title":"Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy.","volume":"38","author":"MD Savvidou","year":"2001","journal-title":"Hypertension"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1161\/01.RES.0000020562.07492.D4","article-title":"Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function.","volume":"90","author":"CP Leeson","year":"2002","journal-title":"Circ Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1745-7270.2008.00369.x","article-title":"Preliminary computational modeling of nitric oxide synthase 3 interactions with caveolin-1: influence of exon 7 Glu298Asp polymorphism.","volume":"40","author":"MS Joshi","year":"2008","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11906-003-0006-0","article-title":"Endothelial nitric oxide synthase polymorphisms and hypertension.","volume":"5","author":"AD Hingorani","year":"2003","journal-title":"Curr Hypertens Rep"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0895-7061(00)00282-X","article-title":"Association analyses of endothelial nitric oxide synthase gene polymorphisms in essential hypertension.","volume":"13","author":"AV Benjafield","year":"2000","journal-title":"Am J Hypertens"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/ki.2008.574","article-title":"Endothelial nitric oxide synthase gene polymorphisms and the renal hemodynamic response to L-arginine.","volume":"75","author":"DZ Cherney","year":"2009","journal-title":"Kidney Int"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/01.HYP.0000033974.57407.82","article-title":"Association of eNOS Glu298Asp polymorphism with end-stage renal disease.","volume":"40","author":"E Noiri","year":"2002","journal-title":"Hypertension"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"144","DOI":"10.5414\/CNP70144","article-title":"Association of endothelial nitric oxide synthase Glu298Asp polymorphism with end-stage renal disease.","volume":"70","author":"M Thaha","year":"2008","journal-title":"Clin Nephrol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1022473405275","article-title":"Association of ecNOS gene polymorphisms with end stage renal diseases.","volume":"244","author":"S Nagase","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/clinchem\/46.11.1858","article-title":"Association of a missense Glu298Asp mutation of the endothelial nitric oxide synthase gene with end stage renal disease.","volume":"46","author":"H Suzuki","year":"2000","journal-title":"Clin Chem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1080\/07853890600969213","article-title":"Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy.","volume":"38","author":"A Mollsten","year":"2006","journal-title":"Ann Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/HJH.0b013e3281268548","article-title":"Lack of association between endothelial nitric oxide synthase gene polymorphisms, microalbuminuria and endothelial dysfunction in hypertensive men.","volume":"25","author":"G Dell'Omo","year":"2007","journal-title":"J Hypertens"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/6675","article-title":"Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation.","volume":"6","author":"TO Fischmann","year":"1999","journal-title":"Nat Struct Biol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1006\/bbrc.2001.5007","article-title":"Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy.","volume":"284","author":"M Jachymova","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/HYPERTENSIONAHA.111.181990","article-title":"Genomewide Association Study Using a High-Density Single Nucleotide Polymorphism Array and Case-Control Design Identifies a Novel Essential Hypertension Susceptibility Locus in the Promoter Region of Endothelial NO Synthase.","volume":"59","author":"E Salvi","year":"2012","journal-title":"Hypertension"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/j.atherosclerosis.2008.12.015","article-title":"The endothelial nitric oxide synthase \u2212786 T>C polymorphism and the exercise-induced blood pressure and nitric oxide responses among men with elevated blood pressure.","volume":"204","author":"AL Augeri","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/j.ajkd.2004.03.034","article-title":"Association between ENOS gene polymorphism and cardiovascular events in nondiabetic hemodialysis patients: a prospective study.","volume":"44","author":"Y Asakimori","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jacc.2006.05.046","article-title":"The T(\u2212786)C endothelial nitric oxide synthase genotype predicts cardiovascular mortality in high-risk patients.","volume":"48","author":"GP Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1440-1797.2008.00925.x","article-title":"Endothelial nitric oxide synthase polymorphisms are associated with hypertension and cardiovascular disease in renal transplantation.","volume":"13","author":"UV Bhandary","year":"2008","journal-title":"Nephrology (Carlton)"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0034217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T00:39:05Z","timestamp":1593909545000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0034217"}},"subtitle":[],"editor":[{"given":"Weili","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,3,28]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0034217","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,28]]}}}